|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Suppression of pancreatic cancer by the dominant negative mutant,N116Y 显示文摘 | Shichinohe T Senmaru N Furuuchi K | 1996 | J Surg Res1996，66，2： | 1 |
| 2 | Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y显示文摘 | Shichinohe T Takeuchi M | 1998 | Int J Cancer1998，78，3： | 1 |
| 3 | The dominant negative H-ras mutant, Nll6Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mics 显示文摘 | Takeuchi M Shichinobe T Senmaru N | 2000 | Gene Ther2000，7，6： | 1 |
| 4 | The dominant negative H-ras mutant, N116Y ,suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice显示文摘 | TaKeuchi M Shichinohe T Senmaru N | 2000 | Gene Therapy2000，7，6： | 1 |
| 5 | Suppression of Erk activation and in vivo growth in esophageal cancer cells, by the dominant negative Ras mutant, N116Y显示文摘 | Senmaru N Shichinohe T Takeuehi U | 1998 | Int J Cancer1998，78，： | 1 |
| 6 | The dominant negative H-ras mutant,N116Y,suppresses growth of metastatic human pancreatic cancer cells in the live of nude mice显示文摘 | TAKEUCHI M SHICHINOHE T SENMARU N | 2000 | Gene Ther2000，7，： | 1 |
| 7 | 收缩压变异性与2型糖尿病患者糖尿病肾病及动脉粥样硬化相关显示文摘近期许多研究显示收缩压变异性对心血管疾病发展有影响。该研究旨在探讨收缩压变异性和2型糖尿病患者糖尿病肾病和动脉粥样硬化严重程度之间的关系。 | Okada H Fukui M Tanaka M Inada S Mineoka Y Nakanishi N Senmaru T Sakabe K Ushigome E Asano M Yamazaki M Hasegawa G Nakamura N 刘莉 叶鹏 | 2012 | 中华高血压杂志2012，20，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员